Symbol
ATHA on Nasdaq
Investment type
Equity / Common Stock, $0.0001 Par Value
Latest Disclosed Shares Owned
0 shares
Security Ownership %
0%

BML Investment Partners, L.P. ownership in Athira Pharma, Inc. Common Stock, $0.0001 Par Value (ATHA)

18 Dec 2025 - BML Investment Partners, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Athira Pharma, Inc. Common Stock, $0.0001 Par Value (ATHA). This represents 0% ownership of the company. In their previous filing dated 14 Feb 2025, BML Investment Partners, L.P. had reported owning 2,484,445 shares, indicating a decrease of +100%. .